Antihypertensive Drugs and COVID-19 Risk

Proposed pharmacological treatments for COVID-19: previously confirmed drugs

Background:     The outbreak of severe acute respiratory syndrome coronavirus-2, also called COVID-19, first appeared in December 2019 in Wuhan, China. COVID-19 is an enveloped single-stranded RNA virus, which has affected more than 14 million people around the world and caused a high rate of mortality. It is notable that discovering new drugs and vaccines against SARS-CoV2 is time consuming. ...

Antihypertensive Drugs

Hypertension is one of the most serious concerns of modern medical practice. It is estimated that in the United States, as many as 60 million people are hypertensive or are being treated with antihypertensive drugs. Among the growing population of elderly Americans, some 15 million have high blood pressure. The level of blood pressure in itself is not a chief concern, since individuals with hig...

Developing a Method for Assessing and Managing the Risk of Covid-19; Rapid Covid-19 Hazard analysis

Background and aims: Work environments are constantly changing under the influence of various factors and newer risks are introduced. Rapid changes in science and technology, increasing the complexity of the industry, increased system integration and other factors have been shown to increase total risk in the past few decades. As well, risk management becomes increasingly critical in decreasing...

Psychological Risk and Protective Factors Related to Fear of Covid-19 During the COVID-19 Pandemic in Iran

The current COVID-19 pandemic is associated with numerous psychological issues such as anxiety and distress as a result of individual, health-related, social, and economic, issues. This study aimed to assess the general population in Iran for negative impacts of the current pandemic on psychological well-being and to find possible protective and risk factors when facing such situations as the c...

Hypertension, antihypertensive drugs and atherosclerosis.